Skip to main content

InvestmentPitch Media Video Discusses Reliq Health’s Continued US Expansion and Signing of 5 New Contracts with Physician Practices in Nevada, California and Texas

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, March 04, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global telemedicine company developing innovative Virtual Care solutions for the multibillion-dollar Healthcare market, has signed 5 new contracts with physician practices in Nevada, California and Texas.

Dr. Lisa Crossley, CEO, stated: “We are very excited to be expanding into Nevada with three new physician practices. Over 1 million residents of Nevada have chronic conditions like hypertension, arthritis, diabetes and kidney disease. Nevada is ranked 47th out of 50 US States in terms of the ratio of physicians to residents, making access to care a significant challenge for patients across the State. Using Reliq’s iUGO Care platform, clinicians in Nevada can provide high quality, proactive, preventative care to more patients, improving access to care and health outcomes for at-risk patients. We are also pleased to add two new primary practices in California and Texas.”

A Media Snippet accompanying this announcement is available by clicking on the image or link below: 

Reliq Health, a rapidly growing global telemedicine company, continues its US expansion, signing 5 new contracts with physician practices in Nevada, California and Texas: Reliq Health, a rapidly growing global telemedicine company, continues its US expansion, adding 5 contracts with physician practices in Nevada, California and Texas, and expects to add more than 2,500 new patients

For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch.com” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Reliq” in the search box.

Together, these five new contracts are expected to add more than 2,500 new patients to the company’s platform with patient onboarding from these practices expected to begin in April. When the 2,500 patients are fully onboarded and generating revenues of US$50 per patient per month, the company anticipates generating revenue of more than CDN$150,000 per month.

The company released its financials for the second quarter earlier this week.

Commenting of these financials, Dr. Crossley stated: “The first two quarters of FY2022 were a period of rapid growth for the company. Revenues for the period from July 1 to December 31, 2021 were $3,748,292 as compared to $843,449 for the period from January 1 to June 30, 2021, an increase of over 344%. Gross Margin improved to 74% in Q2 FY2022 as compared to 58% for FY2021. Despite the dramatic resurgence of COVID (Omicron variant) in Q2 FY2022, the company reached a revenue run rate of $2 Million/month as of December 31, 2021, where run rate represents the number of subscribers onboarded as of the given date.”

Based in Hamilton, Ontario, with offices in Florida and Texas, Reliq specializes in developing innovative Virtual Care solutions for the multibillion-dollar healthcare market. The company’s powerful iUGO Care technology platform is a comprehensive SaaS solution that allows complex patients to receive high-quality care at home, improving health outcomes, enhancing the quality of life for patients and families, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and emergency room visits.

The shares are trading at $0.90. For more information, please visit the company’s website, www.ReliqHealth.com or email IR@ReliqHealth.com. Investor Relations in the United States is handled by Ben Shamsian of Lytham Partners, who can be reached at 649-829-9701 or by email at shamsian@LythamPartners.com.

Disclaimer

The information in this Investmentpitch Media Ltd video is for the viewers information only. Reliq Health Technologies has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format. The corporate information is based on information that is publicly available. Any information provided by Investmentpitch Media Ltd., through its media services is not to be construed as a recommendation or suggestion or offer to buy or sell securities but is provided solely as an informational media service. Investmentpitch Media Ltd makes no warranties or undertakings as to the accuracy or completeness of this information. All due diligence should be done by the viewer or their financial advisor. Investing in securities is speculative and carries risk.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000’s of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.